KRT17 has been proven to be a prognostic marker for a multitude of cancers, including lung cancer [22], colon cancer [30], cervical cancer [31], bladder cancer [32], etc. The ability to predict outcomes and to identify key players in biological mechanisms that lead to poor outcomes are two important objectives in cancer research [15]. The gene discussed is KRT17; the disease is colonic neoplasm.